Properties of Highly Purified Human T Lymphoblast (Molt-4) Deoxycytidine Kinase
N S Datta(University of Michigan), Irving H. Fox(Takeda (United States)), Beverly S. Mitchell(Unknown), Donna S. Shewach(VA Center for Clinical Management Research), Mary C. Hurley(University of Michigan)
Cited by 1
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694